Mpox, once a rare virus mainly confined to parts of Central Africa, is rapidly evolving into a more serious global health ...

Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists at the University of Surrey.

The Mpox virus is related to the original smallpox virus (Variola major). The EMA's decision to approve Imvanex was based on laboratory data showing that the vaccine offers cross-protection.

Since a wave of infections with the Mpox virus swept around the world in 2022, Germany’s Standing Commission on Vaccination (STIKO) has recommended that people at an elevated risk of Mpox ...

While close physical contact remains the dominant mode of transmission, the presence of mpox virus in respiratory fluids, such as mucus and saliva, raises concerns about possible aerosol ...

Health officials announced the opening of 12 new mpox vaccination sites across England last month. This expansion means that every region in the country is now able to offer vaccines to individuals at ...

A month before this, the government announced the purchase of additional mpox vaccine doses to strengthen the country’s defences against the virus. While the UK Health Security Agency (UKHSA ...